Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: Quadria boosts Asian investments

Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.

In Vietnam, it has completed an investment in HCM City-based FV Hospital. Founded by Jean-Marcel Guillon in 2003, the 220-bed hospital has more than 950 service staff, including 130 Vietnamese and expatriate doctors. It is the only joint commission international accredited hospital in South Vietnam. It also operates an outpatient clinic at the heart of District 1, HCM City’s traditional business district.

The investment will be used to build leading diagnostic and treatment centres for selected specialties and to provide access to advanced care in Central and South Vietnam via establishing an integrated network of healthcare facilities across the region.

Other investors who participated in the investment with Quadria include funds managed by Neuberger Berman Private Equity and DEG, the German development finance institution and a subsidiary of KfW.

In Singapore, it has taken a significant stake in MWH Holdings, the holding company for the Singapore Heart, Stroke and Cancer Centre. MWH currently operates out of Paragon Medical Centre and will be expanding its operations this year with a new centre located at Royal Square Novena.

It currently operates under four flagship brands: Singapore Heart, Stroke and Cancer Centre, a specialist centre focused on prevention, early diagnosis and treatment of heart disease, stroke and cancer; Singapore Medical Specialists Centre – multi-specialist centre offering a comprehensive range of specialty care services; Singapore Centre for Medical Imaging, a radiology centre offering a wide range of latest high-end diagnostics modalities; and Face, Body and Skin Aesthetics Medical Center, an aesthetics centre offering non-invasive, minimally invasive and surgical proceedures.

“Whilst we continue to serve the domestic and medical tourism segment out of Singapore, we see a significant opportunity regionally, particularly in the mid-tier segment where patients require something more affordable or for certain conditions where patients are unable to travel for treatment,” said Michael Lim, chief medical officer of MWH. And Quadria will support MWH’s regional growth ambitions through its existing hospital network and relationships.

Quadria Capital has assets exceeding US$1.5 billion and investments in 15 companies across the AsiaPacific region. It closed its third Quadria Capital Fund at US$304 million in June 2015 with two investments in Medica Synergie, the largest hospital network in eastern India, and SOHO Global Health, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia. The investments in Vietnam and Singapore are the sixth and seventh investments from that fund.

Posted on: 12/07/2017 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.